The Potential of Kava in Enabling Tobacco Cessation - Its Holistic Effects in Managing Stress and Insomnia Associated With Abstinence - Trial NCT05814055
Access comprehensive clinical trial information for NCT05814055 through Pure Global AI's free database. This Phase 2 trial is sponsored by University of Florida and is currently Not yet recruiting. The study focuses on Smoking. Target enrollment is 75 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Florida
Timeline & Enrollment
Phase 2
Aug 01, 2023
Jun 01, 2026
Primary Outcome
Subject Compliance with Intervention,Subject Compliance with Intervention
Summary
This study will evaluate the compliance with a daily kava regimen among active smokers who
 have an intention to quit smoking. This study will also investigate whether kava use can
 facilitate tobacco cessation, reduce stress, and improve sleep.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05814055
Non-Device Trial